Katsutoshi Oda

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. ncbi request reprint Xanthogranulomatous inflammation of the perimetrium with infiltration into the uterine myometrium in a postmenopausal woman: a case report
    Tomoko Inoue
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    BMC Womens Health 14:82. 2014
  2. pmc Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423
    Tomoko Kashiyama
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    PLoS ONE 9:e87220. 2014
  3. pmc The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
    K Shoji
    Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan
    Br J Cancer 101:145-8. 2009
  4. pmc Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
    Aki Miyasaka
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo Bunkyo ku, Tokyo 113 8655, Japan
    BMC Cancer 14:179. 2014
  5. ncbi request reprint Cytodiagnostic problems in uterine sarcoma. Analysis according to a novel classification of tumor growth types
    Katsutoshi Oda
    Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Acta Cytol 48:181-6. 2004
  6. doi request reprint PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation
    Katsutoshi Oda
    Cancer Research Institute, Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California, USA
    Cancer Res 68:8127-36. 2008
  7. doi request reprint Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines
    Yuichiro Miyamoto
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113 8655, Japan
    Oncol Rep 29:51-7. 2013
  8. pmc Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas
    Keiko Shoji
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    PLoS ONE 7:e37431. 2012
  9. doi request reprint Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer
    Yuji Ikeda
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    Int J Gynecol Cancer 22:725-31. 2012
  10. doi request reprint Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer
    Yuji Ikeda
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo 113 8655, Japan
    Oncol Rep 30:584-8. 2013

Collaborators

Detail Information

Publications45

  1. ncbi request reprint Xanthogranulomatous inflammation of the perimetrium with infiltration into the uterine myometrium in a postmenopausal woman: a case report
    Tomoko Inoue
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    BMC Womens Health 14:82. 2014
    ....
  2. pmc Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423
    Tomoko Kashiyama
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    PLoS ONE 9:e87220. 2014
    ....
  3. pmc The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
    K Shoji
    Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan
    Br J Cancer 101:145-8. 2009
    ..The AKT1 (E17K) mutation has been reported in some tumour types (breast, colorectal, ovarian and lung cancers), and it is of interest which tumour types other than those possess the E17K mutation...
  4. pmc Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
    Aki Miyasaka
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo Bunkyo ku, Tokyo 113 8655, Japan
    BMC Cancer 14:179. 2014
    ..We examined the anti-tumor activity of olaparib, a PARP inhibitor, and its correlation between the sensitivity and status of PTEN in endometrial cancer cell lines...
  5. ncbi request reprint Cytodiagnostic problems in uterine sarcoma. Analysis according to a novel classification of tumor growth types
    Katsutoshi Oda
    Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Acta Cytol 48:181-6. 2004
    ..To clarify the cytologic diagnostic problems of uterine sarcomas and the differential properties between pure sarcomas and carcinosarcomas...
  6. doi request reprint PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation
    Katsutoshi Oda
    Cancer Research Institute, Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California, USA
    Cancer Res 68:8127-36. 2008
    ..Our data therefore suggest that in tumors with co-occurring mutations in multiple components of the PI3K pathway, selective inhibition of the alpha isoform of p110 is an attractive therapeutic strategy, especially for late-stage tumors...
  7. doi request reprint Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines
    Yuichiro Miyamoto
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113 8655, Japan
    Oncol Rep 29:51-7. 2013
    ....
  8. pmc Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas
    Keiko Shoji
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    PLoS ONE 7:e37431. 2012
    ..Our data suggest that mutational statuses of PTEN and K-Ras might be useful predictors of sensitivity to NVP-BEZ235 in certain endometrial carcinomas...
  9. doi request reprint Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer
    Yuji Ikeda
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    Int J Gynecol Cancer 22:725-31. 2012
    ..Although the prognosis of DP without any metastases is significantly better than that of SPM, pathological diagnosis is difficult in tumors with similar histological features...
  10. doi request reprint Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer
    Yuji Ikeda
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo 113 8655, Japan
    Oncol Rep 30:584-8. 2013
    ..In conclusion, we identified an unreported CCND1 mutation (T286I) in two endometrial cancers and revealed that the mutation was functional for inducing cell proliferation in human cells...
  11. ncbi request reprint hScrib, a human homologue of Drosophila neoplastic tumor suppressor, is a novel death substrate targeted by caspase during the process of apoptosis
    Kenbun Sone
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Genes Cells 13:771-85. 2008
    ..These results indicate that caspase-dependent cleavage of hScrib is a critical step for detachment of cell contact during the process of apoptosis...
  12. doi request reprint Low-grade endometrial stromal sarcoma developing in a postmenopausal woman under toremifene treatment for breast cancer
    Tomoko Kashiyama
    Departments of Obstetrics and Gynecology Pathology, The University of Tokyo, Tokyo, Japan
    J Obstet Gynaecol Res 39:424-9. 2013
    ..The patient discontinued toremifene and has been progression-free for 21 months. Our data suggest that toremifene might be associated with the development of ESS in certain patients through its estrogen-like effects in the uterus...
  13. doi request reprint Retreatment with nedaplatin in patients with recurrent gynecological cancer after the development of hypersensitivity reaction to carboplatin
    Takahide Arimoto
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    J Obstet Gynaecol Res 39:336-40. 2013
    ..The purpose of this retrospective study was to investigate the feasibility of replacing carboplatin with nedaplatin in patients who had developed a hypersensitivity reaction to carboplatin...
  14. doi request reprint The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN
    Satoko Kojima
    Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Bunkyo ku, Tokyo, Japan
    Am J Reprod Immunol 69:134-41. 2013
    ..PD-1 expression on T cells induces Tregs. No studies have quantitatively analyzed the Tregs and PD-1+ cells residing in CIN lesions...
  15. doi request reprint Repression of estrogen receptor beta function by putative tumor suppressor DBC1
    Satoshi Koyama
    Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo 113 8655, Japan
    Biochem Biophys Res Commun 392:357-62. 2010
    ..These results implicate the principal role of DBC1 in regulating ERbeta-dependent gene expressions...
  16. doi request reprint Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression
    Akira Shirane
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Hongo 7 3 1 Bunkyo ku, Tokyo 113 8655, Japan
    Biochem Biophys Res Commun 424:604-10. 2012
    ....
  17. ncbi request reprint Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis
    Takahide Arimoto
    Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108 8639, Japan
    Int J Oncol 22:551-60. 2003
    ..These data should provide useful information for finding candidate genes whose products might serve as molecular targets for diagnosis or treatment of endometriosis...
  18. ncbi request reprint Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report
    Keiko Shoji
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo Bunkyo ku, Tokyo, 113 8655, Japan
    Med Oncol 28:771-4. 2011
    ..Anastrozole was effective to recurrent low-grade ESS even after being refractory to progestin therapy. Aromatase inhibitor treatment may be a useful option as a second-line hormonal treatment to low-grade ESS...
  19. pmc Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models
    Kensuke Tomio
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    PLoS ONE 8:e73085. 2013
    ....
  20. doi request reprint High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: a long-term follow-up retrospective study
    Kanako Inaba
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    J Obstet Gynaecol Res 40:554-60. 2014
    ....
  21. doi request reprint Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner
    Ayumi Taguchi
    Department of Obstetrics and Gynecology, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Vaccine 30:5368-72. 2012
    ....
  22. pmc Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo
    Ayumi Taguchi
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo, Japan
    PLoS ONE 9:e89605. 2014
    ..Our data suggests that omega-3 PUFAs suppress MMP-9 induction and tumor angiogenesis. These findings may provide insight into mechanisms by which omega-3 PUFAs exert anti-tumor effects by modulating tumor microenvironment. ..
  23. pmc Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth
    Aki Yamashita
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Sci Rep 3:3113. 2013
    ..We finally showed that the administration of RvE3 to LPS-exposed pregnant wild type mice lowered the incidence of preterm birth. Our data suggest that RvE3 could be a potential new therapeutic for the prevention of preterm birth. ..
  24. ncbi request reprint Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells
    Kazunori Nagasaka
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Cancer Sci 97:1217-25. 2006
    ..Our findings suggest the possibility that hScrib is involved in signal transduction to negatively regulate cell proliferation by localizing at the basolateral membrane of epithelial cells through LRRs and PDZ domains...
  25. ncbi request reprint Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer
    Tetsushi Tsuruga
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113 8655, Japan
    Oncol Res 16:431-5. 2007
    ..These results indicate that loss of Hugl-1 expression in endometrial cancer may contribute to lymph node metastasis and it can be a factor of poor prognosis...
  26. ncbi request reprint Glomus tumor of the ovary: a case report
    Daichi Maeda
    Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Int J Surg Pathol 18:557-60. 2010
    ..Although an ovarian glomus tumor is extremely rare, the authors believe that it should be included in the differential diagnosis of ovarian mesenchymal tumors and sex cord tumors...
  27. pmc Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary
    Yoshihiro Morita
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7 3 1, Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Reprod Biol Endocrinol 10:14. 2012
    ..To date, the presence and physiological role of SIRT1 in the ovary are not known. Here we found that SIRT1 was localized in granulosa cells of the human ovary...
  28. ncbi request reprint Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer
    Kae Okuma
    Department of Radiology, University of Tokyo Hospital, Hongo, Tokyo, Japan
    J Obstet Gynaecol Res 36:757-63. 2010
    ..A review was conducted in which the effect of age on survival was assessed in a population of endometrial cancer patients treated with surgery and adjuvant radiation therapy in our institution...
  29. doi request reprint Weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with recurrent and refractory ovarian cancer: a preliminary result of 19 cases
    Yuji Ikeda
    Department of Obstetrics and Gynecology, Ohki Memorial Kikuchi Cancer Center for Women, Tokorozawa, Saitama, Japan
    Int J Gynecol Cancer 23:355-60. 2013
    ..Here, we evaluated the effect of weekly low-dose administration of GEMOX in combination with bevacizumab (B-GEMOX) for patients with recurrent and refractory ovarian cancers (ROCs)...
  30. ncbi request reprint High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
    Katsutoshi Oda
    Cancer Research Institute, University of California San Francisco, San Francisco, California 94115, USA
    Cancer Res 65:10669-73. 2005
    ..Our data suggest that the PI3K pathway is extensively activated in endometrial carcinomas, and that combination of PIK3CA/PTEN alterations might play an important role in development of these tumors...
  31. ncbi request reprint Analysis of the status of the novel estrogen receptor α (ERα) coactivator p72 in endometrial cancer and its cross talk with erbB-2 in the transactivation of ERα
    Lin Zhao
    Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113 8655, Japan
    Mol Med Report 1:387-90. 2008
    ..These findings also suggest that the cooperative transactivation of ERα AF-1 by the overexpression of p72, AIB1 and erbB-2 might be involved in tamoxifen-stimulated growth of endometrial cancer...
  32. ncbi request reprint SIRT3 Positively Regulates the Expression of Folliculogenesis- and Luteinization-Related Genes and Progesterone Secretion by Manipulating Oxidative Stress in Human Luteinized Granulosa Cells
    Houju Fu
    Department of Obstetrics and Gynecology H F, O W H, M H, A Sa, A Sh, Y M, W I, K Ko, K O, K Ka Y O, T F and the University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan Department of Physiological Chemistry and Metabolism Y K, W I, H K, Graduate School of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan Department of Obstetrics and Gynecology H O, T Y, National Center for Global Health and Medicine, 1 21 1 Toyama, Shinjyuku ku, Tokyo 162 8655, Japan
    Endocrinology 155:3079-87. 2014
    ..Activation of SIRT3 function might help to sustain human reproduction by maintaining GCs as well as oocytes. ..
  33. doi request reprint Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary
    Sultan Ahmad Halimi
    Department of Pathology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
    Histopathology 63:534-44. 2013
    ..In this study, we attempted to elucidate characteristics of the mucinous epithelium in each subtype...
  34. ncbi request reprint Second-line chemotherapy with docetaxel and carboplatin in paclitaxel and platinum-pretreated ovarian, fallopian tube, and peritoneal cancer
    Takahide Arimoto
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo, 113 8655, Japan
    Med Oncol 29:1253-4. 2012
    ..On the other hand, single-agent chemotherapy would be better than this regimen considering its low response rate and severe hematological toxicity for patients with progression-free interval less than 6 months...
  35. ncbi request reprint Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7
    Katsuyuki Adachi
    Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Vaccine 28:2810-7. 2010
    ..This novel approach at a therapeutic HPV vaccine may achieve more effective clinical responses through its induction of mucosal E7-specific CTL...
  36. doi request reprint β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors
    Daichi Maeda
    Department of Pathology, Graduate School of Medicine, The University of Tokyo, Japan
    Am J Surg Pathol 35:1429-40. 2011
    ..Finally, by comparing the immunophenotype of MCST with its histologic mimics and other ovarian sex cord-stromal tumors, we were able to identify unique features of MCST and a panel of markers useful in differential diagnosis...
  37. ncbi request reprint Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers
    Kei Kawana
    Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyo ku, 113 8655, Tokyo 113 8655, Japan
    Vaccine 21:4256-60. 2003
    ..1mg group and the placebo group recipients. This study suggests the L2-108/120 peptide is tolerable in humans and has the potential as a broad-spectrum prophylactic vaccine against genital HPV...
  38. doi request reprint Cyclin-dependent kinase 4/6-specific activities as a biomarker for prognosis and chemosensitivity in endometrial cancer
    Yujio Ikeda
    The University of Tokyo, Tokyo, Japan
    Obstet Gynecol 123:92S. 2014
    ..We evaluated the clinical importance of CDK4/6 activity and its significance as a novel biomarker for the prognosis and chemosensitivity of endometrioid endometrial carcinoma...
  39. ncbi request reprint Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study
    Hideomi Yamashita
    Department of Radiology, University of Tokyo Hospital, 7 3 1 Hongo, Bunkyou ku, Tokyo 113 8655, Japan
    Gynecol Oncol 97:834-9. 2005
    ..To compare treatment outcome results of conventional surgery vs. radiotherapy (RT) for carcinoma of the uterine cervix...
  40. ncbi request reprint Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas
    Koji Matsumoto
    Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7 3 1, Hongo, Bunkyo ku, Tokyo, Japan
    Cancer Lett 180:83-9. 2002
    ..Interestingly, EC can directly metastasize to both PLN and ALN with PLN metastases being dominant, a distinct lymphatic spread pattern better viewed as being somewhere between CC and OC...
  41. doi request reprint Effective treatment of pelvic lymphocele by lymphaticovenular anastomosis
    Takeshi Todokoro
    Department of Plastic and Reconstructive Surgery, The University of Tokyo, Tokyo, Japan
    Gynecol Oncol 128:209-14. 2013
    ..The aim of this study was to evaluate whether LVA is an effective treatment for lymphocele, which is caused by an obstruction of the lymphatic flow in a manner similar to the development of lymphedema...
  42. ncbi request reprint [Targeting Ras-PI3K/mTOR pathway and the predictive biomarkers in endometrial cancer]
    Katsutoshi Oda
    Dept of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan
    Gan To Kagaku Ryoho 38:1084-7. 2011
    ....
  43. doi request reprint Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta
    Yuki Iwasawa
    Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Bunkyo ku, Tokyo, Japan
    Am J Reprod Immunol 62:90-5. 2009
    ..However, the source of increased ATX during pregnancy is still uncertain. We hypothesized that the source of increased ATX might be placenta...
  44. pmc Genome wide association study of age at menarche in the Japanese population
    Chizu Tanikawa
    Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    PLoS ONE 8:e63821. 2013
    ..In addition, six loci in or near CCDC85A, LOC100421670, CA10, ZNF483, ARNTL, and RXRG exhibited suggestive association with AAM (P<0.05). Our findings elucidated the impact of genetic variations on AAM in the Japanese population...
  45. doi request reprint Primary vaginal calculus in a middle-aged woman with mental and physical disabilities
    Yuji Ikeda
    Department of Obstetrics and Gynecology, Toma Hospital, 2 137 Hirosue, Kumagaya, Saitama 360 0031, Japan
    Int Urogynecol J 24:1229-31. 2013
    ..Results demonstrated the presence of a primary vaginal calculus. Vaginal calculi may occasionally occur in disabled women, but further investigation of the etiology of such calculi is required. ..